Clinical trial
Talampanel in Treating Patients With Recurrent High-Grade Glioma
NCT00064363 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00064363 |
|---|---|
| Title | Talampanel in Treating Patients With Recurrent High-Grade Glioma |
| Official title | A Phase II Trial Of Talampanel In Patients With Recurrent High-Grade Gliomas |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | talampanel |
| Start date | Jun 1, 2003 |
| Completion | Feb 1, 2007 |
| First posted | Jul 9, 2003 |
| Last update posted | Mar 8, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: